Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03663972
Other study ID # 20180510BK01978
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 11, 2018
Est. completion date April 30, 2020

Study information

Verified date June 2020
Source University of Wyoming
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes.


Description:

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. However, these sounds are often treated later in a child's life because they are not expected to be fully acquired until quite late--age 7-8 for some sounds. This practice places treatment in a time of the child's development in which they struggle to learn new sounds.The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes, and to examine treatment efficacy and efficiency for two methods of treatment.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date April 30, 2020
Est. primary completion date April 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 8 Years
Eligibility Inclusionary Criteria:

- Normal Hearing

- Typical Receptive Language

- Speech Sound Disorder

- No motor speech impairment

- Typical non-verbal intelligence

- Produces at least one late-acquired sound with <7% accuracy

- Monolingual English-speaking

- Typical in terms of motoric and neurological development

Exclusionary Criteria:

- Neurological disorder

- Hearing loss

- Nonverbal IQ < 16th percentile

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
articulation therapy
children receive instruction in producing new sounds at the isolation, syllable and word level.
phonologic treatment
children receive instruction in producing new sounds at the word level

Locations

Country Name City State
United States University of Wyoming Laramie Wyoming

Sponsors (1)

Lead Sponsor Collaborator
University of Wyoming

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Treatment Efficacy: Number of correct productions of treated speech sounds in treatment words Accurate Production of treatment sound at baseline and at posttest baseline until accuracy criterion is met; up to 18 weeks after final baseline session
Primary Treatment Efficiency: Number of sessions required to meet accuracy criteria Number of treatment sessions required to meet accuracy criteria (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions) baseline until accuracy criterion is met; up to 18 weeks after final baseline session
Primary Session Length: Mean duration of sessions in minutes Start and end time of session is recorded on scoresheet, then number of minutes for each session for each participant is found and the mean across all sessions is calculated. First treatment session until final treatment session. Final treatment session occurs when accuracy of treatment sound is met (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)
Secondary Accuracy of production of untreated sounds measured on pretest and posttest probes Some children may generalize their skills learned through treatment to sounds that were not treated in the trial. baseline and at posttest up to 18 weeks after final baseline session
See also
  Status Clinical Trial Phase
Recruiting NCT02909088 - Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Phase 2/Phase 3
Recruiting NCT05695131 - Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies N/A
Recruiting NCT04117360 - Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Completed NCT02490826 - Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders N/A
Not yet recruiting NCT04528147 - Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD N/A
Completed NCT02554513 - Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT) N/A
Recruiting NCT05876247 - Articulatory Adaptation Following Oral Cancer Treatment
Recruiting NCT05489965 - Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Completed NCT02752425 - Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation N/A
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT04026581 - Real World Testing of a Brain-Computer Interface
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Completed NCT02416856 - Brain Connectivity Supporting Language Recovery in Aphasia
Completed NCT01180309 - Lingual Frenum and Articulation of Phonemes N/A
Not yet recruiting NCT04323085 - Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease Phase 2
Completed NCT00125242 - Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis N/A
Completed NCT04966689 - The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD) N/A
Completed NCT04009811 - A New Membrane Obturator Prothesis Concept for Soft Palate Defects N/A
Completed NCT00001218 - Development of Normative Ultrasound Databases of Tongue Surface Configuration N/A